Impact on cardiometabolic risk of a weight loss intervention with higher protein from lean red meat: Combined results of 2 randomized controlled trials in obese middle-aged and older adults.

[1]  W. Willett,et al.  Meta-Analysis of Randomized Controlled Trials of Red Meat Consumption in Comparison With Various Comparison Diets on Cardiovascular Risk Factors , 2019, Circulation.

[2]  Lyanne M. Kieneker,et al.  Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type II diabetes mellitus in the Prevention of Renal and Vascular End-Stage Disease study. , 2019, Journal of clinical lipidology.

[3]  Lyanne M. Kieneker,et al.  Plasma Branched-Chain Amino Acids and Risk of Incident Type 2 Diabetes: Results from the PREVEND Prospective Cohort Study , 2018, Journal of clinical medicine.

[4]  Amy Wright,et al.  A Mediterranean-style eating pattern with lean, unprocessed red meat has cardiometabolic benefits for adults who are overweight or obese in a randomized, crossover, controlled feeding trial , 2018, The American journal of clinical nutrition.

[5]  Yongzhong Zhao,et al.  Gut microbiota derived metabolites in cardiovascular health and disease , 2018, Protein & Cell.

[6]  M. Holick,et al.  Dietary Protein and Preservation of Physical Functioning Among Middle-Aged and Older Adults in the Framingham Offspring Study , 2018, American journal of epidemiology.

[7]  J. Koh,et al.  The positive association of total protein intake with femoral neck strength (KNHANES IV) , 2018, Osteoporosis International.

[8]  C. Bales,et al.  Obesity Interventions for Older Adults: Diet as a Determinant of Physical Function. , 2018, Advances in nutrition.

[9]  J. Kremer,et al.  Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies , 2018, Annals of the rheumatic diseases.

[10]  M. Connelly,et al.  A novel NMR-based assay to measure circulating concentrations of branched-chain amino acids: Elevation in subjects with type 2 diabetes mellitus and association with carotid intima media thickness. , 2018, Clinical biochemistry.

[11]  A. Astrup,et al.  Dietary Intake of Protein from Different Sources and Weight Regain, Changes in Body Composition and Cardiometabolic Risk Factors after Weight Loss: The DIOGenes Study , 2017, Nutrients.

[12]  S. Hazen,et al.  NMR quantification of trimethylamine-N-oxide in human serum and plasma in the clinical laboratory setting. , 2017, Clinical biochemistry.

[13]  M. Connelly,et al.  GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk , 2017, Journal of Translational Medicine.

[14]  Olga V. Demler,et al.  Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: The Women's Health Study. , 2017, Journal of clinical lipidology.

[15]  W. Kraus,et al.  Association of the Composite Inflammatory Biomarker GlycA, with Exercise-Induced Changes in Body Habitus in Men and Women with Prediabetes , 2017, Oxidative medicine and cellular longevity.

[16]  C. Pieper,et al.  Influence of Protein Intake, Race, and Age on Responses to a Weight-Reduction Intervention in Obese Women , 2017, Current developments in nutrition.

[17]  A. Sanyal,et al.  Nonalcoholic steatohepatitis is associated with a state of betaine‐insufficiency , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[18]  L. Räber,et al.  Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors , 2017, European heart journal.

[19]  J. Cauley,et al.  The Association Between Protein Intake by Source and Osteoporotic Fracture in Older Men: A Prospective Cohort Study , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  D. Bluemke,et al.  GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis. , 2016, Circulation research.

[21]  D. Raj,et al.  Trimethylamine N-Oxide: The Good, the Bad and the Unknown , 2016, Toxins.

[22]  A. Kitabchi,et al.  Remission of pre-diabetes to normal glucose tolerance in obese adults with high protein versus high carbohydrate diet: randomized control trial , 2016, BMJ Open Diabetes Research and Care.

[23]  M. Connelly,et al.  Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects , 2016, Lipids in Health and Disease.

[24]  M. Connelly,et al.  Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[25]  D. Ellsworth,et al.  Lifestyle modification interventions differing in intensity and dietary stringency improve insulin resistance through changes in lipoprotein profiles , 2016, Obesity science & practice.

[26]  W. Cromwell,et al.  Clinical utility of LDL particle number to optimize management of LDL-related cardiovascular risk , 2016 .

[27]  D. Jacobs,et al.  Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events. , 2016, Clinical chemistry.

[28]  P. Ridker,et al.  Circulating N‐Linked Glycoprotein Side‐Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial , 2016, Journal of the American Heart Association.

[29]  M. Fitó,et al.  Polyphenol rich olive oils improve lipoprotein particle atherogenic ratios and subclasses profile: A randomized, crossover, controlled trial. , 2016, Molecular nutrition & food research.

[30]  N. Paynter,et al.  Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial. , 2016, JAMA cardiology.

[31]  W. Kraus,et al.  A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls , 2016, Arthritis Research & Therapy.

[32]  P. Njølstad,et al.  Prospective Associations of Systemic and Urinary Choline Metabolites with Incident Type 2 Diabetes. , 2016, Clinical chemistry.

[33]  L. Sands,et al.  Effects of dietary protein intake on body composition changes after weight loss in older adults: a systematic review and meta-analysis. , 2016, Nutrition reviews.

[34]  Thomas J. Wang,et al.  Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program , 2016, Diabetes.

[35]  J. Murabito,et al.  Mid‐adulthood cardiometabolic risk factor profiles of sarcopenic obesity , 2016, Obesity.

[36]  C. Pieper,et al.  Improved Function With Enhanced Protein Intake per Meal: A Pilot Study of Weight Reduction in Frail, Obese Older Adults , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  M. Connelly,et al.  GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function , 2015, PloS one.

[38]  D. Volkert,et al.  Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons – a narrative review , 2015, Clinical interventions in aging.

[39]  C. Bales,et al.  Excessive Body Weight in Older Adults. , 2015, Clinics in geriatric medicine.

[40]  M. Connelly,et al.  GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. , 2015, Clinical chemistry.

[41]  M. Connelly,et al.  HDL particle number measured on the Vantera®, the first clinical NMR analyzer. , 2015, Clinical biochemistry.

[42]  M. Carnethon,et al.  Lipoprotein Particles and Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis , 2015, Diabetes Care.

[43]  M. Connelly,et al.  NMR measurement of LDL particle number using the Vantera Clinical Analyzer. , 2014, Clinical biochemistry.

[44]  P. Ridker,et al.  A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events , 2014, Journal of the American Heart Association.

[45]  M. Connelly,et al.  Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance. , 2014, Metabolic syndrome and related disorders.

[46]  S. Hazen,et al.  Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. , 2014, European heart journal.

[47]  M. Sheffield-Moore,et al.  Dietary Protein Distribution Positively Influences 24-h Muscle Protein Synthesis in Healthy Adults123 , 2014, The Journal of nutrition.

[48]  M. Cesari,et al.  Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. , 2013, Journal of the American Medical Directors Association.

[49]  J. Larrick,et al.  Dietary modification of the microbiome affects risk for cardiovascular disease. , 2013, Rejuvenation research.

[50]  S. Hazen,et al.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.

[51]  J. Wells,et al.  Sarcopenic obesity: A Critical appraisal of the current evidence. , 2012, Clinical nutrition.

[52]  D. Mozaffarian,et al.  Unprocessed Red and Processed Meats and Risk of Coronary Artery Disease and Type 2 Diabetes – An Updated Review of the Evidence , 2012, Current Atherosclerosis Reports.

[53]  Clifford Qualls,et al.  Weight loss, exercise, or both and physical function in obese older adults. , 2011, The New England journal of medicine.

[54]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[55]  Mark A. Newman,et al.  Impact of Weight Loss on Physical Function with Changes in Strength, Muscle Mass, and Muscle Fat Infiltration in Overweight to Moderately Obese Older Adults: A Randomized Clinical Trial , 2010, Journal of obesity.

[56]  F. Hu,et al.  Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. , 2010, The American journal of clinical nutrition.

[57]  L. Groop,et al.  Minimal Contribution of Fasting Hyperglycemia to the Incidence of Type 2 Diabetes in Subjects With Normal 2-h Plasma Glucose , 2009, Diabetes Care.

[58]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[59]  W. Cromwell,et al.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. , 2006, Clinics in laboratory medicine.

[60]  W. Campbell,et al.  Total red meat intake of ≥0.5 servings/d does not negatively influence cardiovascular disease risk factors: a systemically searched meta-analysis of randomized controlled trials. , 2017, The American journal of clinical nutrition.

[61]  M. Singer,et al.  High-Protein Foods and Physical Activity Protect Against Age-Related Muscle Loss and Functional Decline , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[62]  J. Cauley,et al.  High dairy protein intake is associated with greater bone strength parameters at the distal radius and tibia in older men: a cross-sectional study , 2017, Osteoporosis International.

[63]  Jacob P. Kelly,et al.  A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality. , 2017, Clinical chemistry.

[64]  C. Pieper,et al.  Meal-based enhancement of protein quality and quantity during weight loss in obese older adults with mobility limitations: rationale and design for the MEASUR-UP trial. , 2015, Contemporary clinical trials.

[65]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .